TEAS Response to Suspension Inquiry

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1822 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1822 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Response to Suspension Inquiry or Letter of Suspension

To the Commissioner for Trademarks:

Application serial no. 88484180 XCOPRI (Stylized and/or with Design, see http://uspto.report/TM/88484180/mark.png) has been amended as follows:
FOREIGN APPLICATION(S)
The applicant herein elects NOT to proceed to registration under Section 44(e) for any foreign application(s) claimed as a basis for priority.

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: The applicant has had a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

Filing Basis: Section 44(d), Priority based on foreign filing: Applicant has had a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [Korea, South application number 40-2019-0096 filed 06/21/2019]. 15 U.S.C.Section 1126(d), as amended.

Proposed: Class 005 for Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets
Filing Basis: Section 1(b), Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

Filing Basis: Section 44(d), Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [Korea, South application number 40-2019-0096 filed 06/21/2019]. 15 U.S.C.Section 1126(d), as amended.
INTENT TO PERFECT 44(d) : System experiences issues when trying to connect to message retriever


The applicant's current attorney information: Diane J. Mason. Other appointed attorneys are Diane J. Mason. Diane J. Mason of DRINKER BIDDLE & REATH LLP, and the attorney(s) is located at

      FOUR EMBARCADERO CENTER, 27TH FLOOR
      SAN FRANCISCO, California
      US

The phone number is 415-591-7506.

The email address is sftrademarks@dbr.com

The applicants proposed attorney information: Diane J. Mason. Diane J. Mason of DRINKER BIDDLE & REATH LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at

      FOUR EMBARCADERO CENTER, 27TH FLOOR
      SAN FRANCISCO, California 94111
      United States

The phone number is 415-591-7506.

The email address is sftrademarks@dbr.com

Diane J. Mason submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current correspondence information: DIANE J. MASON. Other appointed attorneys are Diane J. Mason. DIANE J. MASON of DRINKER BIDDLE & REATH LLP, and the attorney(s) is located at

      FOUR EMBARCADERO CENTER, 27TH FLOOR
      SAN FRANCISCO, California
      US

The phone number is 415-591-7506.

The email address is sftrademarks@dbr.com; sftrademarks@dbr.com

The applicants proposed correspondence information: Diane J. Mason. Diane J. Mason of Drinker Biddle & Reath LLP, is located at

      Four Embarcadero Center, 27th Floor
      San Francisco, California 94111
      United States

The phone number is 4155917506.

The email address is sftrademarks@dbr.com; sftrademarks@dbr.com

Response Suspension Inquiry Signature
Signature: /djm/     Date: 11/27/2019
Signatory's Name: Diane J. Mason
Signatory's Position: Attorney of Record, California Bar
Signatory's Phone Number: 4155917506

Mailing Address:    DIANE J. MASON
   DRINKER BIDDLE & REATH LLP
   
   FOUR EMBARCADERO CENTER, 27TH FLOOR
   SAN FRANCISCO, California
Mailing Address:    Diane J. Mason
   Drinker Biddle & Reath LLP
   Four Embarcadero Center, 27th Floor
   San Francisco, California 94111
        
Serial Number: 88484180
Internet Transmission Date: Wed Nov 27 13:23:18 EST 2019
TEAS Stamp: USPTO/RSI-XX.XX.XX.X-2019112713231879045
3-88484180-700853a60ae6354eecc2eac1a2443
b6a6bb024a792eb289aa318ceb26a984cea-N/A-
N/A-20191127115510894907